LINK ALTERNATIF MBL77 Options
Not all individuals with CLL require therapy. Inspite of all modern advances, the iwCLL continue to endorses watchful observation for patients with asymptomatic disease.86 This recommendation is predicated on not less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (